Brugada syndrome: From diagnosis to treatment

Aneta Kucharczyk-Foltyn; Maria Śnieżek-Maciejewska; Maciej Dymek; Jerzy Sadowski; Marianna Janion

Vol 14, No 5 (2007)

Review Article

Submitted: 2013-01-14

Published online: 2007-08-02

View PDF

Download PDF file

Get Citation

Brugada syndrome: From diagnosis to treatment

Aneta Kucharczyk-Foltyn, Maria Śnieżek-Maciejewska, Maciej Dymek, Jerzy Sadowski, Marianna Janion

Cardiol J 2007;14(5):429-435.

Vol 14, No 5 (2007)

Review articles

Submitted: 2013-01-14

Published online: 2007-08-02

Abstract

Brugada syndrome is electrocardiographically characterised by ST segment elevation in right precordial leads and the occurrence of episodes of polymorphic ventricular tachycardia. It is also associated with a high risk of sudden death, which may be the first manifestation of the disease. Various mutations of SCN5A gene encoding for the cardiac sodium channel are among the proven causes of BS. ICD remains the only treatment for BS of proven efficacy. However, many questions about etiology, underlying mechanisms, safety of asymptomatic patients and treatment options for BS remain unanswered. (Cardiol J 2007; 14: 429-435)